综合性转录和实验分析确定了与原相关的枢纽基因,弥合了慢性过敏性肺炎和肺癌
Sanjukta Dasgupta1, Bishnupriya Saha2, Subhendu Chakrabarty3
1Department of Biotechnology, Brainware University, Barasat, India; Center for Multidisciplinary Research & Innovations, Brainware University, Barasat, India.
慢性过敏性肺炎 (CHP) 和肺癌 (LC) 分享原蛋白基因失调. 硫酸阿尔布特显示出作为向治疗的潜力,对肺癌细胞表现出选择性细胞毒性.
科学领域:
- 肺部病理学 肺部病理学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 慢性过敏性肺炎 (CHP) 可以进展为肺纤维化并增加肺癌 (LC) 风险.
- 在CHP和LC之间共享的分子路径尚未完全理解,特别是关于细胞外矩阵 (ECM) 重塑.
研究的目的:
- 在CHP和LC之间识别共同的分子特征.
- 研究原相关基因在疾病进展中的作用.
- 探索潜在的治疗点,包括硫酸.
主要方法:
- 转录形状分析以识别差异表达的基因.
- 网络分析以确定枢纽基因.
- 使用支气管支气管支气管洗液进行实验验证.
- 在的药物基因相互作用和分子对接.
- 在体外细胞毒性测定.
主要成果:
- 确定了158个常见的差异表达基因,其中9个枢纽基因主要参与原生物合成和ECM组织.
- 在这两种条件下,五个原蛋白基因 (COL10A1,COL22A1,COL7A1,COL5A2,COL17A1) 都被显著上调.
- 硫酸对原具有中度的结合亲和力,对A549肺癌细胞具有选择性细胞毒性,对正常纤维细胞的毒性最小.
结论:
- 原蛋白失调是CHP和LC之间的关键分子联系.
- 硫酸 (Albuterol sulfate) 是针对纤维化和瘤性肺部疾病中的原相关途径的潜在治疗候选者.
- 综合计算和实验方法可以揭示复杂的肺病理的新型治疗策略.
更多相关视频
04:42Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
Published on: March 21, 2025
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Fibril-associated Collagen
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-I: Introduction
The JAK-STAT Signaling Pathway
